Pretreatment analysis of AMH level is of value in predicting long term ovarian function in women with breast cancer but its value in other diagnoses and with other types of chemotherapy regimen, particularly when less gonadotoxic are unclear. The gene discussed is AMH; the disease is breast cancer.